Cargando…
Risk stratification in differentiated thyroid cancer with RAI-avid lung metastases
OBJECTIVE: Radioactive iodine (RAI) therapy is effective for differentiated thyroid cancer (DTC) patients with lung metastasis. However, some patients have a poor prognosis despite the RAI accumulation. The utility of inflammatory biomarkers, including neutrophil-to-lymphocyte ratio (NLR), has been...
Autores principales: | Ohkuwa, Keiko, Sugino, Kiminori, Nagahama, Mitsuji, Kitagawa, Wataru, Matsuzu, Kenichi, Suzuki, Akifumi, Tomoda, Chisato, Hames, Kiyomi, Akaishi, Junko, Masaki, Chie, Ito, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346177/ https://www.ncbi.nlm.nih.gov/pubmed/34223823 http://dx.doi.org/10.1530/EC-21-0215 |
Ejemplares similares
-
Preoperative inflammatory markers for predicting parathyroid carcinoma
por: Ohkuwa, Keiko, et al.
Publicado: (2022) -
Rapid disease progression after discontinuation of lenvatinib in thyroid cancer
por: Yamazaki, Haruhiko, et al.
Publicado: (2020) -
Stereotactic radiotherapy using the CyberKnife is effective for local control of bone metastases from differentiated thyroid cancer
por: Ishigaki, Takayuki, et al.
Publicado: (2019) -
Response to neoadjuvant paclitaxel predicts survival in anaplastic thyroid carcinoma
por: Yamazaki, Haruhiko, et al.
Publicado: (2022) -
Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients
por: Masaki, Chie, et al.
Publicado: (2021)